)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Sichuan Kelun Pharmaceutical
Sichuan Kelun Pharmaceutical (002422) investor relations material
Sichuan Kelun Pharmaceutical 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary15 Jan, 2026
Company overview and strategy
Focuses on R&D, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other diseases.
Operates a differentiated drug-conjugate technology platform, OptiDC, with over 30 pipeline programs.
Employs around 2,000 staff, with significant R&D, manufacturing, and sales teams.
Strategic partnerships with major global firms, including MSD, to maximize pipeline and corporate value.
Expanding business landscape and capabilities for global product development and commercialization.
Pipeline highlights and clinical progress
Four approved products with seven indications; two products at NDA stage; over 10 in clinical development.
TROP2 ADC (sac-TMT) launched in China in November 2024, first globally approved for lung cancer.
HER2-ADC approved for HER2-positive breast cancer; cetuximab and PD-L1 also available.
Multiple pivotal clinical studies ongoing for breast, lung, and GI cancers; data presented at major conferences.
Three core products included in China's national reimbursement drug list (NRDL 2025).
Product performance and innovation
sac-TMT demonstrated best-in-class efficacy and safety in phase three trials for lung and breast cancer.
HER2-ADC showed significant improvement in PFS and ORR compared to T-DM1 in phase three studies.
GI cancer pipeline includes cetuximab for colorectal cancer and ADCs targeting gastric and pancreatic tumors.
OptiDC platform enables tailored drug design, novel payloads, and bispecific ADCs for enhanced efficacy.
Exploring non-oncology ADCs for autoimmune and metabolic diseases, aiming for better safety and efficacy.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Sichuan Kelun Pharmaceutical earnings date
H2 20253 Apr, 2026
Sichuan Kelun Pharmaceutical
Next Sichuan Kelun Pharmaceutical earnings date
H2 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sichuan Kelun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio includes intravenous (IV) solutions, antibiotics, oncology treatments, and other specialty drugs, serving hospitals, healthcare facilities, and pharmacies. Sichuan Kelun focuses on developing generic and innovative drugs to address various therapeutic areas, including infectious diseases, oncology, and chronic conditions. In addition to pharmaceuticals, the company is involved in biotechnology research to expand its product offerings. The company is headquartered in Chengdu, China, and its shares are listed on the Shenzhen Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage